Friday, June 26, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 849 of 1,261
  1. US 8551467

    Replenishment and enrichment of ocular surface lubrication

    The Regents of the University of California · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  2. US 8551536

    Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  3. US 8551726

    Method of modulating HSF-1

    Northwestern University · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  4. US 8551966

    Chemical compounds

    University College Cardiff Consultants Limited · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  5. US 8551997

    Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use

    The Board of Regents of the University of Texas System · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  6. US 8551945

    Methods and compositions for treating neuropathies

    Sangamo Biosciences, Inc. · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  7. US 8551978

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance, Inc. · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  8. US 8552037

    Tricyclic compound and pharmaceutical use thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  9. US 8552167

    Multifunctional aptamer-nucleic acid nanostructures for tumor-targeted killing

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  10. US 8552150

    MART-1 T cell receptors

    The Regents of the University of California · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  11. US 8552147

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  12. US 8552198

    Benzimidazole compound crystal

    Takeda Pharmaceutical Company Limited · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  13. US 8552067

    Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses therefor

    The Regents of the University of California · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  14. US 8552088

    Cement for dental applications

    KURARAY NORITAKE DENTAL INC. · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  15. US 8552006

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  16. US 8551935

    Benefit agent containing delivery particle

    Appleton Papers Inc. · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  17. US 8552034

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  18. US 8551936

    Defensin-antigen fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  19. US 8551526

    Preparation of drug particles using evaporation precipitation into aqueous solutions

    The Board of Regents of the University of Texas System · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  20. US 8552018

    Substituted tricyclic compounds as protein kinase inhibitors

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  21. US 2013261160

    METHOD OF PREPARATION OF METAXALONE

    IACOANGELI TOMMASO [IT] · Granted Oct 3, 2013 · Expires Sep 28, 2033

    granted
  22. US 8545225

    Redox-curing type composition

    KURARAY NORITAKE DENTAL INC. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  23. US 8545847

    Human antibodies to the human glucagon receptor and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  24. US 8545927

    Lactoferrin-based biomaterials for tissue regeneration and drug delivery

    UNIVERSITY OF CONNECTICUT · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.